New FRONTIER5 results show a direct switch to investigational Mim8 (denecimig) prophylaxis treatment from emicizumab, without the need for a washout period, was well-tolerated in adults and ...

Hemophilia A is a rare, inherited condition that prevents your blood from clotting the way it should. People with hemophilia A do not make enough of a protein called factor VIII, which normally works ...

Hemophilia disease is a rare inherited bleeding disorder. People with this genetic condition do not produce sufficient clotting factors, which can cause uncontrolled external or internal bleeding.

What Is Alhemo, and Why Does It Matter? Alhemo (concizumab-mtci) is a medicine approved to help prevent bleeding in people aged 12 or older with hemophilia A or B who don’t have inhibitors to certain ...

Living with hemophilia B can be scary. But treatment is so effective that people who have hemophilia generally live just as long as people who don’t have the ...

SAN RAFAEL, Calif., Aug. 30, 2023 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (BMRN), a global biotechnology company dedicated to transforming lives through genetic discovery, today announced that an ...

Detailed price information for Chugai Pharmaceutical (CHGCF) from The Globe and Mail including charting and trades.

When Allison Sandford-Sweatman’s then four-year-old son Griffin was accidentally kicked in the leg by another player, she felt she had no choice but to pull him out of soccer. As a mom to a child with ...

The U.S. Food and Drug Administration today approved Idelvion, Coagulation Factor IX (Recombinant), Albumin Fusion Protein, for use in children and adults with Hemophilia B. Idelvion is the first ...